Quality of life issues in psoriasis

Journal of the American Academy of Dermatology

Volumn 49, Issue 2 A, 2003, Pages 57-61

  Choi, Jane ^a   Koo, John Y M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC DISEASE; DISABILITY; DISEASE SEVERITY; HEALTH CARE COST; HEALTH SURVEY; HUMAN; PRIORITY JOURNAL; PSORIASIS; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SHORT FORM 36; SKIN DISEASE; SOCIAL ASPECT;

EID: 0042634224     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Jobling RG. Psoriasis - a preliminary questionnaire study of sufferers' subjective experience. Clin Exp Dermatol 1976;1:233-6.
2. Koo J. Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment. Dermatol Clin 1996; 14: 485-96.
3. Wahl AK, Gjengedal E, Hanestad BR. The bodily suffering of living with severe psoriasis: in depth interviews with 22 hospitalized patients with psoriasis. Qual Health Res 2002;12:250-61.
4. Zachariae R, Zachariae H, Blomqvist K, Davidsson S, Molin L, Mork C, et al. Quality of life in 6497 Nordic patients with psoriasis. Br J Dermatol 2002;146:1006-16.
5. Fortune DG, Richards HL, Main CJ, Griffiths CE. What patients with psoriasis believe about their condition. J Am Acad Dermatol 1998;39(2 pt 1):196-201.
6. Krueger GG, Feldman SR, Camisa C, Duvic M, Elder JT, Gottlieb AB, et al. Two considerations for patients with psoriasis and their clinicians: What defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis? J Am Acad Dermatol 2000;43(2 pt 1):281-5.
7. Ramsey B, O'Reagan M. A survey of the social and psychological effects of psoriasis. Br J Dermatol 1988;188:195-201.
8. Gupta MA, Schork NJ, Gupta AK. Pruritus in psoriasis. A prospective study of some psychiatric and dermatologic correlates. Arch Dermatol 1988;124:1052-7.
9. Rapp SR, Feldman SR, Exum ML, Fleischer AB Jr, Reboussin DM. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999;41(3 Pt 1):401-7.
10. Gupta MA, Gupta AK. Quality of life of psoriasis patients. J Eur Acad Dermatol Venereol 2000;14:241-2.
11. Devrimci-Ozguven H, Kundakci TN, Kumbasar H, Boyvat A. The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients. J Eur Acad Dermatol Venereol 2000; 14:267-71.
12. Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol 1998;139:846-50.
13. Fried RG, Friedman S, Paradis C, Hatch M, Lynfield Y, Duncanson C, et al. Trivial or terrible? The psychosocial impact of psoriasis. Int J Dermatol 1995;34:101-5.
14. Wahl A, Loge JH, Wiklund I, Hanestad BR. The burden of psoriasis: a study concerning health-related quality of life among Norwegian adult patients with psoriasis compared with general population norms. J Am Acad Dermatol 2000;43(5 Pt 1):803-8.
15. Schmid-Ott G, Kuensebeck HW, Jaeger B, Ott R, Lamprecht F. Dimensions of stigmatization in patients with psoriasis in a 'questionnaire on experience with skin complaints.' Dermatology 1996;193;304-10.
16. Gupta MA, Gupta AK, Watteel GN. Perceived deprivation of social touch in psoriasis is associated with greater psychologic morbidity: an index of the stigma experience in dermatologic disorders. Cutis 1998;61:339-42.
17. Fortune DG, Main CJ, O'Sullivan TM, Griffiths CE. Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress. Br J Dermatol 1997;137:755-60.
18. Gupta MA, Gupta AK. Age and gender differences in the impact of psoriasis on quality of life. Int J Dermatol 1995;34:700-3.
19. Gupta MA, Gupta AK. Psoriasis and sex: a study of moderately to severely affected patients. Int J Dermatol 1997;36:259-62.
20. Ginsberg IH, Link BG. Psychosocial consequences of rejection and stigma feelings in psoriasis patients. Int J Dermatol 1993;32: 587-91.
21. Feldman SR, Fleischer AB Jr, Reboussin DM, Rapp SR, Bradham DD, Exum ML, et al. The economic impact of psoriasis increases with psoriasis severity. J Am Acad Dermatol 1997;37:564-9.
22. Finlay AY, Coles EC. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol 1995;132:236-44.
23. O'Neill P, Kelly P. Postal questionnaire study of disability in the community associated with psoriasis. BMJ 1996;313:919-21.
24. Ware JE, Snow KK, Kosinski M, Gandek B. Boston: Mass: The Health Institute, New England Medical Center; 1993.
25. Lundberg L, Johannesson M, Silverdahl M, Hermansson C, Lindberg M. Quality of life, health-state utilities and willingness to pay in patients with psoriasis and atopic eczema. Br J Dermatol 1999;141:1067-75.
26. Blumenschein K, Johannesson M. Relationship between quality of life instruments, health-state utilities and willingness to pay in patients with asthma. Ann Allergy Asthma Immunol 1998;80: 189-94.
27. Finlay AY, Kelly SE. Psoriasis - an index of disability. Clin Exp Dermatol 1987;12:8-11.
28. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994;19:210-6.
29. Koo JYM, Menter A, Lebwohl M, Kozma CM, Endzweig C, Abramovits W. The relationship between quality of life and disease severity: results from a large cohort of mild, moderate, and severe psoriasis patients. Submitted for publication 2003.
30. Kirby B, Richards HL, Woo P, Hindle E, Main CJ, Griffiths CE. Physical and psychologic measures are necessary to assess overall psoriasis severity. J Am Acad Dermatol 2001;45:72-6.
31. Finlay AY. The outcomes movement and new measures of psoriasis. J Am Acad Dermatol 1997;36(3 Pt 1):502-3.